Discover the in’s and out’s of our solutions in a private demo
Canada
In Canada, TB continues to affect people in the country, though at much lower rates than in many other parts of the world.
41.3 million
population
2,300 people
developed TB in 2023
93 people
lost their lives to the disease
Our work in Canada
2017
We have supported research at McGill University in Montreal, Quebec, by providing CAD4TB for academic and clinical studies.
2022
We provided an additional CAD4TB to further their research.
Research studies
Multiple publications from McGill University researchers highlight the use and evaluation of CAD4TB in diverse settings.
Connect with our representative in your country.
We work alongside Ministries of Health, implementing partners, and healthcare providers to ensure solutions are aligned with national strategies and local healthcare systems.
Florent Geerts
- Review which solutions align with your programmatic and operational needs
- Explore partnership opportunities and long-term collaboration
- Address technical, clinical, and infrastructure considerations specific to your setting